These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 7478555
1. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene. Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Konishi M, Kawashima I, Takamoto S, Hirai H, Miyaki M. Oncogene; 1995 Oct 05; 11(7):1339-45. PubMed ID: 7478555 [Abstract] [Full Text] [Related]
2. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Bristow RG, Jang A, Peacock J, Chung S, Benchimol S, Hill RP. Oncogene; 1994 Jun 05; 9(6):1527-36. PubMed ID: 8183546 [Abstract] [Full Text] [Related]
3. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ. Cell Growth Differ; 1990 Dec 05; 1(12):571-80. PubMed ID: 2288874 [Abstract] [Full Text] [Related]
4. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ, Austin VN, Zimmer SG, Fisher PB. Oncogene; 1993 May 05; 8(5):1211-9. PubMed ID: 8479744 [Abstract] [Full Text] [Related]
5. The p53 tumor suppressor gene and gene product. Levine AJ. Princess Takamatsu Symp; 1989 May 05; 20():221-30. PubMed ID: 2488233 [Abstract] [Full Text] [Related]
6. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B. Yam JW, Chan KW, Hsiao WL. Oncogene; 2001 Jan 04; 20(1):58-68. PubMed ID: 11244504 [Abstract] [Full Text] [Related]
7. Nuclear localization is essential for the activity of p53 protein. Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V. Oncogene; 1991 Nov 04; 6(11):2055-65. PubMed ID: 1719467 [Abstract] [Full Text] [Related]
8. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination. Taylor WR, Egan SE, Mowat M, Greenberg AH, Wright JA. Oncogene; 1992 Jul 04; 7(7):1383-90. PubMed ID: 1620551 [Abstract] [Full Text] [Related]
9. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135). Yam JW, Zheng JY, Hsiao WL. Biochem Biophys Res Commun; 1999 Dec 20; 266(2):472-80. PubMed ID: 10600527 [Abstract] [Full Text] [Related]
10. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts. Peacock JW, Matlashewski GJ, Benchimol S. Oncogene; 1990 Dec 20; 5(12):1769-74. PubMed ID: 2178238 [Abstract] [Full Text] [Related]
15. Transforming activity of mutant human p53 alleles. Slingerland JM, Benchimol S. J Cell Physiol; 1991 Sep 20; 148(3):391-5. PubMed ID: 1918170 [Abstract] [Full Text] [Related]
16. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation. Du Villard JA, Wicker R, Crespo P, Russo D, Filetti S, Gutkind JS, Sarasin A, Suárez HG. Oncogene; 2000 Oct 05; 19(42):4896-905. PubMed ID: 11039907 [Abstract] [Full Text] [Related]
17. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes. Gloushankova N, Ossovskaya V, Vasiliev J, Chumakov P, Kopnin B. Oncogene; 1997 Dec 11; 15(24):2985-9. PubMed ID: 9416842 [Abstract] [Full Text] [Related]
18. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation. Yehiely F, Oren M. Cell Growth Differ; 1992 Nov 11; 3(11):803-9. PubMed ID: 1467307 [Abstract] [Full Text] [Related]
19. p53 mutations and tetraploids under r- and K-selection. Chikatsu N, Nakamura Y, Sato H, Fujita T, Asano S, Motokura T. Oncogene; 2002 May 02; 21(19):3043-9. PubMed ID: 12082535 [Abstract] [Full Text] [Related]
20. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion. Tuck SP, Crawford L. Oncogene Res; 1989 May 02; 4(2):81-96. PubMed ID: 2654816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]